Skip to content
aiqbench

Ask across articles

Ask a question and get an answer built from the site's news articles — every claim cited to its source.

Try one question free — no account needed. Sign in to keep asking

Asking about: “OncoTraj: a public benchmark for longitudinal resistance prediction in EGFR-mutant non-small-cell lung cancer on osimertinib” · arXivClear scope

Try asking

Each question is answered on its own from the indexed articles. A follow-up chip re-asks your question from a new angle; it does not carry the previous answer.